Meg M. McGilley
Keine laufenden Positionen mehr
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Richard Pascoe | M | 60 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 5 Jahre |
David Hale | M | 75 |
Women First HealthCare, Inc.
Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 12 Jahre |
Jeffrey W. Raser | M | 63 |
Women First HealthCare, Inc.
Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 2 Jahre |
Susan E. Dubé | F | 75 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.
Women First HealthCare, Inc.
Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA. | 11 Jahre |
Debra P. Crawford | F | 66 |
Women First HealthCare, Inc.
Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA. | 2 Jahre |
Thomas Wiggans | M | 72 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 4 Jahre |
Saundra Pelletier | F | 54 |
Women First HealthCare, Inc.
Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA. | - |
Robert Lewis Jones | M | 79 |
Women First HealthCare, Inc.
Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA.
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 3 Jahre |
Scott Glenn | M | 73 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 4 Jahre |
Kurt von Emster | M | 56 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 8 Jahre |
Matthew Onaitis | M | 53 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 7 Jahre |
Brian Dorsey | M | 55 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 8 Jahre |
Erle T. Mast | M | 61 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 5 Jahre |
Kenneth M. Cohen | M | 68 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 5 Jahre |
Anthony P. Maris | M | - |
Women First HealthCare, Inc.
Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA. | - |
Cam Garner | M | 75 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | - |
Wendy Johnson | F | 72 |
Women First HealthCare, Inc.
Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA. | 2 Jahre |
Philip Jochelson | M | 63 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 4 Jahre |
Jesse I. Treu | M | 76 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 7 Jahre |
Hazel Aker | F | 68 |
Women First HealthCare, Inc.
Women First HealthCare, Inc. Publishing: Books/MagazinesConsumer Services Women First HealthCare, Inc. is a specialty pharmaceutical company which provides pharmaceutical and self-care products to women and is dedicated to improving the health and well-being of midlife women. The company markets its products in the United States through a number of channels including its sales force, direct-to-consumer marketing programs through internet sites, womenfirst.com and www.aswechange.com and through its As We Change national mail order catalog. It was founded on November 1, 1996 and is headquartered in San Diego, CA. | 1 Jahre |
Kurt C. Wheeler | M | 71 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 5 Jahre |
Louis C. Bock | M | 59 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | - |
Dan Turner | M | 62 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 4 Jahre |
James J. L'Italien | M | 71 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 2 Jahre |
Terrell A. Cobb | M | 74 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 25 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Meg M. McGilley
- Persönliches Netzwerk